Biomerieux SA - Unsponsored ADR (BMXXY)
OTC
Closed
Sep 25, 2026
Day's Range
9.3352 wk Range
7.12Overview - BMXXY - Biomerieux SA - Unsponsored ADR
Key Statistics
Valuation
Enterprise Value
12.24B
P/E (Trailing)
‪21.20‬
Price / Sales (TTM)
‪2.75‬
Price / Book
‪2.24‬
EV / EBITDA
‪10.22‬
Profitability
Profit Margin
‪11.59%‬
Operating Margin
‪15.23%‬
Return on Assets
‪7.23%‬
Return on Equity
‪11.22%‬
Ownership
Shares Outstanding
117.69M
Float
400.24M
Price stats
Beta
‪0.57‬
50-Day Avg
‪8.51‬
200-Day Avg
‪10.48‬
Dividends
Payout Ratio
‪25.33%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BMXXY - Biomerieux SA - Unsponsored ADR
Peers - BMXXY - Biomerieux SA - Unsponsored ADR
Peer Comparison
Compared with companies in Diagnostics & Research listed on OTC.
- BMXXYOTCBiomerieux SA - Unsponsored ADR10.88BMarket Cap-56.70%52-week change21.20P/E (Trailing)‪11.59%‬Profit Margin
- WUXIFOTCWuXi AppTec Co., Ltd.80.47BMarket Cap+47.20%52-week change24.11P/E (Trailing)‪42.25%‬Profit Margin
- LZAGYOTCLonza Group AG49.17BMarket Cap+5.83%52-week change36.76P/E (Trailing)‪-1.60%‬Profit Margin
- ERFSFOTCEurofins Scientific SE15.50BMarket Cap+20.64%52-week change27.24P/E (Trailing)‪7.17%‬Profit Margin
- BMXMFOTCBiomerieux 69 Marcy L'Etoile10.00BMarket Cap-58.84%52-week change19.23P/E (Trailing)‪11.59%‬Profit Margin
- SKHHYOTCSonic Healthcare Limited - Sponsored ADR6.60BMarket Cap-5.94%52-week change15.22P/E (Trailing)‪5.59%‬Profit Margin
- SKHCFOTCSonic Healthcare Limited6.18BMarket Cap-22.54%52-week change13.41P/E (Trailing)‪5.59%‬Profit Margin
Profile Summary - BMXXY - Biomerieux SA - Unsponsored ADR
About
Biomerieux SA is a global leader in in-vitro diagnostics, focusing on the development and production of systems used for clinical applications and industrial microbiological controls. An Unsponsored American Depositary Receipt (ADR) allows Biomerieux SA to trade in the U.S. financial markets, specifically on the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
